To view this page ensure that Adobe Flash Player version 11.1.0 or greater is installed.
NEWS + NOTES
friends Celebrity Poker Event Benefits Center for
Duchenne Muscular Dystrophy at UCLA
Photography by Chris Kirskey
(From left) Drs. Melissa Spencer, Stanley F. Nelson and M. Carrie Miceli, co-directors of the Center for Duchenne Muscular Dystrophy at UCLA; award recipient Dr. David T. Feinberg;
and Amy Martin, community liaison for the center, with her husband Chris Martin. Both the Martins and Drs. Miceli and Nelson have a son with Duchenne muscular dystrophy.
More than 600 people attended the 7th annual Dealing for Duchenne
Texas Hold ’Em poker tournament and silent auction on May
10, 2014, at Sony Pictures Studios. The star-studded event raised
$650,000 for the Center for Duchenne Muscular Dystrophy at UCLA,
one of a handful of facilities in the nation offering comprehensive
care, clinical trials and translational research for Duchenne muscular
dystrophy. American Idol finalist Jessica Sanchez, the Canadian
quartet The Tenors and Grammy Award-winning musician/
producer David Foster provided live music and entertainment at
the gala, hosted by Mad Men actor Joel Murray.
Hard Rock Café co-founder Peter Morton presented Dr. David
T. Feinberg (RES ’92, FEL ’94), president of UCLA Health System,
with the Meyer-Whalley Instrument of Change Award for his
48 U MAGAZINE
support of the center. The award is named for Tom Whalley, former
CEO and chairman of Warner Bros., and his wife Melanie Meyer,
who were instrumental in raising money to launch the Center for
Duchenne Muscular Dystrophy at UCLA.
Duchenne muscular dystrophy strikes one-in-3,500 boys,
weakening their muscles until they lose the ability to move and
breathe on their own. UCLA researchers and physicians combine
their efforts to extend the lives of children with the deadly genetic
disorder. Dealing for Duchenne was launched seven years ago
by local parents Amy and Chris Martin, who have a son affected
by the disease. Proceeds from the event have led to promising
experimental therapies.